
Selinexor Shows Potential Role in PI-Naive Relapsed Multiple Myeloma
With rapidly evolving regimens in the front line of multiple myeloma treatment, patients are eligible for a diverse range of options after the first relapse based on their age, comorbidities, and what agents they are refractory to. The question of how to …